Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Revenue

Hua Medicine (Shanghai) had revenue of 378.90M CNY in the half year ending June 30, 2026, with 269.08% growth. This brings the company's revenue in the last twelve months to 654.41M, up 76.55% year-over-year. In the year 2025, Hua Medicine (Shanghai) had annual revenue of 492.93M with 92.63% growth.

• Revenue (ttm): 654.41M CNY
• Revenue Growth: +76.55%
• P/S Ratio: 3.04
• Revenue / Employee: 1.54M CNY
• Employees: 424
• Market Cap: 2.30B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	492.93M	237.04M	92.63%
Dec 31, 2024	255.89M	179.28M	234.02%
Dec 31, 2023	76.61M	59.01M	335.31%
Dec 31, 2022	17.60M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error